CPT code 96549 denotes unlisted or miscellaneous chemotherapy administration procedures used when no specific CPT code exists for the service performed. This code matters nationally because it provides a billing pathway for novel, atypical, or otherwise uncoded chemotherapy infusion techniques and ensures clinicians can document and seek payment for administered cancer therapies not captured by specific administration codes.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how 96549 is used in clinical oncology settings—primarily infusion centers and outpatient oncology clinics—and what to expect in payer coverage and coding practice. The publication outlines common modifiers associated with chemotherapy administration, the service context for 96549, and implications for claims processing when services lack a specific administration code.

This article provides benchmarks and policy context relevant to national payers, explains typical documentation elements required for unlisted chemotherapy administration, and highlights operational considerations for billing and claims adjudication. Data not available in the input are clearly noted where applicable.